Kidney medicine · 2026
Diagnostic Accuracy of Bone Turnover Markers in Patients With CKD: A Systematic Review and Meta-Analysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Phannajit Jeerath, Jintanapramote Kavita, Takkavatakarn Kullaya, Wipattanakitcharoen Aschariya, Praditpornsilpa Kearkiat, Eiam-Ong Somchai, Susantitaphong Paweena
Аннотация
RATIONALE & OBJECTIVE: Abnormal bone turnover in chronic kidney disease (CKD) increases fracture risk and influences treatment response, making accurate assessment essential. Although bone histomorphometry is the diagnostic gold standard, its invasiveness limits routine use. This study evaluated the diagnostic accuracy of noninvasive bone turnover markers-tartrate-resistant acid phosphatase 5b (TRAP5b), bone-specific alkaline phosphatase (BALP), and procollagen type I N-terminal propeptide (PINP)-compared with parathyroid hormone (PTH) for detecting high or low bone turnover in CKD.
STUDY DESIGN: A systematic review and meta-analysis of observational studies.
SETTING & STUDY POPULATIONS: Adult patients with CKD (all stages).
SELECTION CRITERIA FOR STUDIES: Studies were included if they compared serum bone turnover markers to bone histomorphometry.
DATA EXTRACTION: Two reviewers independently extracted study characteristics, population details, assay types, cutoff thresholds, sensitivity, specificity, and area under the ROC curve (AUC).
ANALYTICAL APPROACH: A meta-analysis using random-effects models pooled AUCs for detecting high and low bone turnover per marker including intact PTH. Subgroup analyses assessed assay types (mass-based vs activity-based BALP, intact vs total PINP) and CKD stages.
RESULTS: Eight studies were included with 6 studies providing AUC data for pooling. Intact PINP and BALP (mass assay) demonstrated the highest accuracy for identifying high bone turnover, whereas intact PTH showed only moderate discriminatory performance. For low turnover, TRAP5b, BALP, and intact PINP displayed comparable accuracy, while total PINP and PTH were less reliable. Reported diagnostic thresholds varied but generally yielded sensitivities of 50%-90% and specificities of 60%-95%. One study suggested that combining bone turnover markers, such as PINP with BALP or TRAP5b, may further enhance diagnostic discrimination.
LIMITATIONS: Limited representation of non-hemodialysis populations, small sample sizes, and lack of standardized methods to determine thresholds.
CONCLUSIONS: TRAP5b, BALP, and intact PINP demonstrated moderate diagnostic accuracy and may support treatment decisions in CKD when bone biopsy is not feasible. (PROSPERO: CRD420251003120).
STUDY DESIGN: A systematic review and meta-analysis of observational studies.
SETTING & STUDY POPULATIONS: Adult patients with CKD (all stages).
SELECTION CRITERIA FOR STUDIES: Studies were included if they compared serum bone turnover markers to bone histomorphometry.
DATA EXTRACTION: Two reviewers independently extracted study characteristics, population details, assay types, cutoff thresholds, sensitivity, specificity, and area under the ROC curve (AUC).
ANALYTICAL APPROACH: A meta-analysis using random-effects models pooled AUCs for detecting high and low bone turnover per marker including intact PTH. Subgroup analyses assessed assay types (mass-based vs activity-based BALP, intact vs total PINP) and CKD stages.
RESULTS: Eight studies were included with 6 studies providing AUC data for pooling. Intact PINP and BALP (mass assay) demonstrated the highest accuracy for identifying high bone turnover, whereas intact PTH showed only moderate discriminatory performance. For low turnover, TRAP5b, BALP, and intact PINP displayed comparable accuracy, while total PINP and PTH were less reliable. Reported diagnostic thresholds varied but generally yielded sensitivities of 50%-90% and specificities of 60%-95%. One study suggested that combining bone turnover markers, such as PINP with BALP or TRAP5b, may further enhance diagnostic discrimination.
LIMITATIONS: Limited representation of non-hemodialysis populations, small sample sizes, and lack of standardized methods to determine thresholds.
CONCLUSIONS: TRAP5b, BALP, and intact PINP demonstrated moderate diagnostic accuracy and may support treatment decisions in CKD when bone biopsy is not feasible. (PROSPERO: CRD420251003120).